Stability of Azasetron-Dexamethasone Mixture for Chemotherapy-Induced Nausea and Vomiting Administration

Oncotarget - United States
doi 10.18632/oncotarget.22174
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Dronabinol for Chemotherapy-Induced Nausea and Vomiting Unresponsive to Antiemetics

Cancer Management and Research
Oncology
2016English

Cannabinoids for Control of Chemotherapy Induced Nausea and Vomiting: Quantitative Systematic

BMJ
2001English

Corticosteroids in the Treatment of Chemotherapy-Induced Nausea and Vomiting

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Efficacy of Triple Antiemetic Therapy (Palonosetron, Dexamethasone, Aprepitant) for Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Carboplatin-Based, Moderately Emetogenic Chemotherapy.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting

Malignant tumours
2018English

Ramosetron Versus Palonosetron in Combination With Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Chemotherapy-Induced Nausea and Vomiting: Exploring Patients’ Subjective Experience

Journal of Multidisciplinary Healthcare
MedicineNursing
2016English

Antiemetics for Chemotherapy-Induced Nausea and Vomiting Occurring Despite Prophylactic Antiemetic Therapy

Journal of Palliative Medicine
MedicineAnesthesiologyPain MedicineNursing
2011English

Treatment of Nausea and Vomiting During Chemotherapy

Oncology & Hematology Review (US)
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy